Samuel Hochstrasser’s practice focuses on domestic and cross-border M&A, capital markets and private equity transactions. His expertise includes corporate, commercial and contract law. He has particular knowledge of the life sciences sector, advising on regulatory and legal in life science matters.

Deals & Cases

Global Blue and Far Point Acquisition Corporation announce USD 2.6bn business combination
Discover More
NKF advises Landis+Gyr Group, Toshiba Corporation and INCJ in the IPO of Landis+Gyr on SIX Swiss Exchange
Discover More
Actelion: Cash offer by Johnson & Johnson and demerger of R&D operations
Discover More


Recent matters in which Samuel acted as counsel include:

  • Landis+Gyr Group and its shareholders Toshiba and INCJ in the dual track exit process resulting in the CHF 2.3 billion IPO of Landis+Gyr Group on SIX, the largest Swiss IPO of the past 10 years and second largest IPO in Europe 2017
  • Actelion in connection with the public tender offer by Johnson & Johnson to the shareholders of Actelion and in connection with the demerger of Idorsia from Actelion
  • BioTelemetry, Inc. in connection with its competing public tender offer to the shareholders of LifeWatch AG
2020 LL.M., Keio University, Tokyo, Gerald P. McAlinn Price in International and Comparative Law
2016 Admitted to the Bar, Rechtsanwalt
2014 University of St. Gallen, Master of Arts HSG in Law and Economics
2012 University of Texas, School of Law, Exchange Semester
2011 University of St. Gallen, Bachelor of Arts HSG in Law and Economics
  • Swiss Bar Association
  • Zurich Bar Association
  • HSG Alumni
2022 Senior Associate, Niederer Kraft Frey
2017 Associate, Niederer Kraft Frey
2015 Clerk with the District Court of Aarau
2014 Junior Associate, Niederer Kraft Frey




Deals & Cases


Swiss Steel successfully completes divestiture of Eastern European entities

Discover More

R&S Group enters into Business Combination Agreement with VT5

Discover More

Macquarie Asset Management closes up to USD 325m investment in Atlas Agro

Discover More

Market Perception

«Samuel Hochstrasser is a super attorney. I’ve always been impressed by him.»
Chambers 2023 – Healthcare & Life Sciences

Awards & Rankings


NKF receives European Corporate Deal of the Year Award at The Lawyer European Awards ceremony

Discover More

Firm News


NKF promotes four senior associates as of 1 July 2022

Discover More

In the Media


The stock corporation law reform (finally) reaching its goal

Discover More